Academic detailing interventions significantly improved more than half of evidence-based prescribing outcomes.

Patients with skin of color are less likely to be diagnosed with a borderline reaction to patch testing than patients with lighter skin tones.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

A new strain of bird flu, H5N9, has been detected for the first time in the United States, raising concerns about how it continues to spread.

According to a recent study, comorbid chronic inflammatory diseases influence the prognosis of alopecia areata.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

A recent study finds that genetically predicted rheumatoid arthritis is causally associated with prostate cancer.

Achievement of cancer remission was associated with dermatomyositis complete clinical response among patients with cancer-associated DM.

Fractional carbon dioxide laser treatments are effective at reducing postsurgical scarring, particularly in the first month after surgery.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

The majority of patients with postacute sequelae of COVID-19/post-COVID-19 syndrome do not recover in the second year of their illness.

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.